• LAST PRICE
    2.9500
  • TODAY'S CHANGE (%)
    Trending Down-0.2600 (-8.0997%)
  • Bid / Lots
    2.8100/ 10
  • Ask / Lots
    3.1000/ 2
  • Open / Previous Close
    2.9700 / 3.2100
  • Day Range
    Low 2.6815
    High 3.0887
  • 52 Week Range
    Low 2.2432
    High 12.0000
  • Volume
    124,462
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 3.21
TimeVolumeLIPO
09:32 ET15203.0001
09:33 ET7703.006
09:35 ET11913.0254
09:37 ET4913.0009
09:39 ET7313
09:42 ET1002.99
09:44 ET13472.9701
09:46 ET11702.96
09:48 ET36783.0475
09:50 ET141082.76
09:51 ET27782.81
09:55 ET5592.81
09:57 ET2002.82
10:02 ET1502.89
10:04 ET5762.91
10:15 ET4002.8884
10:18 ET1002.88
10:27 ET1002.86
10:29 ET1252.82
10:31 ET1002.82
10:33 ET13662.76
10:36 ET10702.71
10:51 ET11002.76
10:56 ET10452.81
10:58 ET3002.81
11:12 ET2002.79
11:23 ET3962.7317
11:25 ET1002.7787
11:30 ET2002.79
11:39 ET1002.84
12:01 ET2002.8
12:03 ET1782.7801
12:06 ET1002.82
12:08 ET4832.88
12:17 ET1002.8662
12:48 ET5002.8449
01:00 ET5002.86
01:06 ET8122.83
01:08 ET2502.8001
01:09 ET7502.8886
01:11 ET6002.89
01:29 ET1002.8484
01:40 ET2692.87
02:02 ET3482.8101
02:07 ET4502.84
02:18 ET2002.86
02:39 ET117612.88
02:41 ET56032.92
02:43 ET58553
02:45 ET39003.0689
02:48 ET10003.0887
02:50 ET25003.025
02:52 ET5893
03:03 ET3002.96
03:06 ET7003.02
03:12 ET31002.9831
03:15 ET3002.96
03:17 ET3002.99
03:21 ET1502.98
03:24 ET1002.95
03:26 ET2002.95
03:28 ET8003
03:30 ET13412.99
03:37 ET1002.96
03:39 ET1002.96
03:42 ET1002.95
03:44 ET9502.95
03:51 ET1022.96
03:53 ET24422.9
03:55 ET25152.96
03:57 ET1002.93
04:00 ET28882.95
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLIPO
Lipella Pharmaceuticals Inc
3.9M
-0.6x
---
United StatesBDRX
Biodexa Pharmaceuticals PLC
3.0M
0.0x
---
United StatesAZTR
Azitra Inc
4.0M
0.0x
---
United StatesADTX
Aditxt Inc
3.2M
0.0x
---
United StatesPALI
Palisade Bio Inc
2.9M
-0.1x
---
United StatesONCT
Oncternal Therapeutics Inc
3.8M
-0.1x
---
As of 2024-11-12

Company Information

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Its lead product candidates include LP-10, LP-310 and LP-410. LP-10 is the development name of its reformulation of tacrolimus specifically optimized for topical deposition to the internal surface of the urinary bladder lumen using a proprietary drug delivery platform. LP-310 is the development name of its oral, liposomal formulation of tacrolimus specifically optimized for local delivery to oral mucosa. It is also developing an oral, liposomal formulation of tacrolimus, LP-410, for the treatment of oral graft-versus-host disease (GVHD). LP-410 is an oral rinse, like LP-310, but has a different containment system. LP-410 targets the underlying mechanisms of oral GVHD, potentially providing a safe and effective treatment option for affected individuals.

Contact Information

Headquarters
400 N Lexington St Ste Ll103PITTSBURGH, PA, United States 15208
Phone
412-901-0315
Fax
302-658-3694

Executives

Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary
Jonathan Kaufman
Chief Financial Officer
Douglas Johnston
Chief Medical Officer, Director
Micheal Chancellor
Independent Director
Lori Birder
Independent Director
Daniel Cohen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.9M
Revenue (TTM)
$507.2K
Shares Outstanding
1.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-4.95
Book Value
$4.16
P/E Ratio
-0.6x
Price/Sales (TTM)
7.7
Price/Cash Flow (TTM)
---
Operating Margin
-839.15%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.